Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Tricida Inc (TCDA)

Tricida Inc (TCDA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Tricida to Report Second Quarter 2020 Financial Results and Host Conference Call and Webcast on Wednesday, August 5, 2020

Tricida, Inc. (Nasdaq: TCDA) today announced that it will report its second quarter 2020 financial results after the close of market on Wednesday, August 5, 2020. Tricida will host a conference call and...

TCDA : 13.75 (+2.77%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tricida, Inc. - TCDA

Pomerantz LLP is investigating claims on behalf of investors of Tricida, Inc. ("Tricida" or the "Company") (NASDAQ: TCDA). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com...

TCDA : 13.75 (+2.77%)
Tricida (TCDA) Plummets on Regulatory Update on Veverimer

Tricida (TCDA) tanks on FDA notification about the identification of deficiencies in its ongoing review of the NDA for pipeline candidate, veverimer (TRC101).

BMRN : 122.04 (+1.86%)
EBS : 118.00 (+6.08%)
HZNP : 63.07 (+3.07%)
TCDA : 13.75 (+2.77%)
Tricida Provides Regulatory Update on Veverimer

Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to...

TCDA : 13.75 (+2.77%)
Hercules Capital Announces Multiple Portfolio Company Achievements in Q2 2019

Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture growth stage companies backed by some of the leading U.S. and...

TCDA : 13.75 (+2.77%)
INSM : 27.15 (+3.94%)
AVEO : 4.43 (+3.99%)
GNCA : 3.18 (+11.58%)
MYOV : 15.79 (+3.88%)
AQ : 13.24 (unch)
MRVL : 37.37 (+2.47%)
VICL : 0.68 (-15.68%)
PINS : 36.08 (+5.22%)
TMDX : 18.84 (+4.32%)
FSLY : 111.66 (+15.72%)
HTGC : 11.53 (+4.44%)
HCXZ : 25.00 (unch)
HCXY : 25.75 (unch)
Tricida Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

Tricida, Inc. (Nasdaq: TCDA) today announced the closing of its previously announced public offering of 6,440,000 shares of its common stock at a public offering price of $36.00 per share,...

JPM : 96.10 (-0.56%)
TCDA : 13.75 (+2.77%)
The Zacks Analyst Blog Highlights: Alpine, Actinium, Molecular Templates, Tricida and Otonomy

The Zacks Analyst Blog Highlights: Alpine, Actinium, Molecular Templates, Tricida and Otonomy

OTIC : 3.41 (-2.85%)
ATNM : 0.6000 (+4.11%)
ALPN : 10.50 (-8.70%)
MTEM : 11.50 (+4.83%)
TCDA : 13.75 (+2.77%)
Tricida Announces Pricing of Public Offering of Common Stock

Tricida,Inc. (Nasdaq: TCDA) today announced the pricing of its public offering of 5,600,000 shares of its common stock at a public offering price of $36.00 per share for total gross proceeds...

JPM : 96.10 (-0.56%)
TCDA : 13.75 (+2.77%)
Small Drugmakers Outperforming the Bigshots: 7 Stocks to Buy

Smaller drugmakers are having a relatively better 2019 than their larger counterparts. Here are seven stocks to buy.

ATNM : 0.6000 (+4.11%)
OTIC : 3.41 (-2.85%)
KALV : 10.94 (+11.29%)
ACRX : 1.1200 (+2.75%)
MTEM : 11.50 (+4.83%)
ALPN : 10.50 (-8.70%)
TCDA : 13.75 (+2.77%)
Tricida Announces Proposed Public Offering of Common Stock

Tricida,Inc. (Nasdaq: TCDA) today announced that it has commenced an underwritten public offering of 5,000,000 shares of its common stock. All of the shares in the offering will be sold by...

JPM : 96.10 (-0.56%)
TCDA : 13.75 (+2.77%)
Will Tricida Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor in Tricida.

TCDA : 13.75 (+2.77%)
Tricida Announces $200 Million Debt Facility With Hercules Capital

Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its drug candidate TRC101 (veverimer), a non-absorbed, orally-administered polymer...

TCDA : 13.75 (+2.77%)
HTGC : 11.53 (+4.44%)
Tricida Inc to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 28, 2019 / Tricida Inc (NASDAQ: ) will be discussing their earnings results in their 2018 Fourth Quarter Earnings to be held on March 28, 2019 at 8:00 AM Eastern Time....

TCDA : 13.75 (+2.77%)

Van Meerten Stock Picks

Ebay - Pick of the Day
Today Ebay (EBAY) is a Volume Leader on Barchart: 100% technical buy signals Trend Spotter buy signal Above its 20, 50 and 100 Day moving averages 16 new highs and up 26.
EBAY +1.29
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar